Replies to post #480 on China Medicine Corporation (CHME)

[Blitzkrieg9]

The 4th quarter loss includes a $.19/share non-cash expense related to the change in the fair value of warrants, per new GAAP guidelines that went into effect Janurary 2009.

Overall, i think these numbers look good and i'm surprised by the selloff. I think this creates a buying opportunity. JMHO.

blitz!